Evidence map›Paper›PMID 26195002›Full record

ArticleBMC public health2015

Chlamydia trachomatis, Neisseria gonorrhoeae and syphilis among men who have sex with men in Brazil.

Cynthia B Cunha, Ruth K Friedman, Raquel B de Boni, Charlotte Gaydos, Maria R C Guimarães, Brenda H Siqueira, Sandra W Cardoso, Leonardo Chicayban, José R Coutinho, Carolyn Yanavich and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Prevalence of chlamydia and gonorreheae among transgender women and travestis in five Brazilian capitals, 2019-2021.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2024
    Article
  4. Prevalence ofEpidemiology and infection · 2023
    Article
  5. Review
  6. Article
  7. Public policies on sexually transmitted infections in Brazil.Revista da Sociedade Brasileira de Medicina Tropical · 2021
    Article
  8. Brazilian Protocol for Sexually Transmitted Infections 2020: acquired syphilis.Revista da Sociedade Brasileira de Medicina Tropical · 2021
    Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. An Update on the Global Epidemiology of Syphilis.Current epidemiology reports · 2018
    Article
  15. Article
  16. Sexually transmitted infections of the lower gastrointestinal tract.Virchows Archiv : an international journal of pathology · 2018
    Review
  17. Syphilis testing practices in the Americas.Tropical medicine & international health : TM & IH · 2017
    Article
  18. Article
  19. Anogenital infection by Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-infected men and women in Salvador, Brazil.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Cynthia B CunhaLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. ccunhav@gmail.com.
Ruth K FriedmanLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. ruthkf@gmail.com.
Raquel B de BoniLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. raqueldeboni@gmail.com.
Charlotte GaydosDivision of Infectious Diseases, John Hopkins University, Baltimore, USA. cgaydos@jhmi.edu.
Maria R C GuimarãesLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. mreginacg@hotmail.com.
Brenda H SiqueiraLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. brenda.fiocruz@gmail.com.
Sandra W CardosoLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. dra.wagner@gmail.com.
Leonardo ChicaybanLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. leonardo.chicaybam@ini.fiocruz.br.
José R CoutinhoLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. jose.coutinho@ini.fiocruz.br.
Carolyn YanavichLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. cmyanavich@gmail.com.
Valdilea G VelosoLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. valdilea.veloso@gmail.com.
Beatriz GrinsztejnLaboratory of Clinical Research in STD/AIDS, Evandro Chagas National Institute of Infectious Diseases (INI-Fiocruz), Rio de Janeiro, Brazil. gbeatriz@ini.fiocruz.br.
Johns Hopkins University · US

Funding

LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)UM1AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SUSAN H ESHLEMAN, Mark A Marzinke · 2011 to 2026
$100.2M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
HIV Prevention Trials Network: Network LaboratoryU01AI068613 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ESHLEMAN, SUSAN H · 2006 to 2010
$16.5M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)U01AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI GRINSZTEJN, BEATRIZ · 2008 to 2011
$14.0M
NIAID NIH HHS UM1 AI068613NIAID NIH HHS UM1 AI069476
6 · The paper itself

Abstract

backgroundSexually transmitted diseases (STD) are frequently asymptomatic and increase the likelihood of transmitting and acquiring HIV. In Brazil, the guidelines for STDs diagnosis and treatment are based on the syndromic approach. Nucleic acid amplification tests (NAAT) has been recommended as routine STDs screening in some countries, especially for men who have sex with men (MSM). Limited data are available about how to best define target groups for routine screening by NAATs within this population. We aimed to assess the prevalence of rectal and urethral Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections and syphilis, and the factors associated with having at least one STD among HIV-infected and uninfected MSM in Rio de Janeiro, Brazil.

methodsFrom August 2010 to June 2012, 391 MSM were enrolled into the Evandro Chagas National Institute of Infectious Diseases-INI-Fiocruz cohort, and 292 MSM (HIV-infected:211 and HIV-uninfected:81) were included in this study. NAATs were performed on the rectal swabs and urine for CT and NG. The rapid plasma reagin test and microhemagglutination assay for Treponema pallidum were performed for syphilis diagnosis.

resultsThe overall prevalence of STD was 20.0% (95%CI:15.7-25.1): 10% anorectal chlamydia; syphilis 9.9%; anorectal gonorrheae 2.5%; and urethral chlamydia 2.2%; no case of urethral gonorrheae was detected. The proportion of HIV-positive MSM who had at least one STD was nearly two times that of HIV-negative MSM (22.6% vs 13.2%; P = 0.09). The frequency of each STD, except for anorectal NG (1.5% vs.5.2%), was higher among HIV-positive than HIV-negative individuals. Among the 211 asymptomatic participants, 17.5% (n = 37) were identified as having at least one STD; 10.4% (n = 22/211) tested positive for anorectal chlamydia. Sixty five percent of HIV-positive MSM were asymptomatic at the time of the STD diagnosis, while 100.0% of the HIV-negative MSM. Age (APR = 0.78; 95%CI:0.60-1.00 for each additional ten years) and a positive-HIV serostatus (APR = 2.05; 95%CI:1.03-4.08) were significantly associated with STD diagnosis.

conclusionAn overall high STD-prevalence rate was observed, especially among HIV-infected and in younger individuals, and the majority of STDs were asymptomatic. STD screening using NAATs among asymptomatic MSM is a potentially cost-effective intervention for the prevention of HIV infection among MSM.

Indexed as

AdultBrazilChlamydia InfectionsChlamydia trachomatisCross-Sectional StudiesGonorrheaHIV InfectionsHomosexuality, MaleHumansMaleMass ScreeningMiddle AgedNeisseria gonorrhoeaeNucleic Acid Amplification TechniquesPrevalenceSexually Transmitted Diseases, Bacterial

Identifiers

PMID26195002
PMCPMC4509695
OpenAlexW2170271040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.